-
NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance
The National Medical Products Administration (NMPA) conducted its 2025 annual management review of the Quality Management System (QMS) for regulation of vaccine and drug Good Manufacturing Practice (GMP) compliance on June 30. NMPA Commissioner Huang Guo presided over the meeting and fully affirmed the suitability, adequacy and effectiveness of the NMPA's QMS in both areas.
-
NMPA holds meeting on vaccine regulatory QMS
To advance the development of China's National Regulatory Authority (NRA) for vaccines and further enhance the country's vaccine regulatory capacity, the National Medical Products Administration (NMPA) held a working meeting on the development of the vaccine regulatory quality management system (QMS) in Changzhou, Jiangsu province, on June 12.
-
Yang Sheng meets with Danish ambassador and chairman of Novo Nordisk
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), held talks with Michael Christensen, Denmark's ambassador to China, and Lars Sorensen, chairman of Danish global pharma group Novo Nordisk, on June 15 in Beijing.
- Announcement of the National Medical Products Administration on Strengthening Supervision and Administration of Contract Manufacturing of Drugs (No. 134, 2025)
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on Strengthening Supervision and Administration of Contract Manufacturing of Drugs (No. 134, 2025)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
